IMMUNOTHERAPY OF LUNG CANCER. IN THE DOCTOR'S OFFICE...

Discover the latest knowledge on immunotherapy of lung cancer with this publication from the series "In the Specialist's Office. Oncology". Under the scientific editorship of Dr. habil. n. med. Kamila Wojas-Krawczyk, this monograph is an invaluable source of information for clinical oncologists and specialists from other medical fields.

• Comprehensive discussion of predictive factors for immunotherapy of lung cancer.
• Innovative therapeutic forms in the first and second line of treatment in NSCLC patients.
• Combination therapies involving immunotherapy.
• Combination of chemotherapy and immunotherapy in the treatment of NSCLC and DRP.
• Discussion of complications of immunotherapy and their treatment.

This monograph discusses with great accuracy the key issues related to immunotherapy of lung cancer, including predictive factors, innovative therapeutic forms and combination therapies. Particular emphasis is placed on the combination of chemotherapy and immunotherapy and various immunotherapy methods in patients with NSCLC and DRP. The publication is primarily dedicated to clinical oncologists, but the topics covered will also be of interest to geneticists, pathologists and pulmonologists, as well as specialists from other fields who encounter cancer patients in their daily practice.

In the publication you will find detailed information on the use of immunotherapy as an innovative therapeutic form in the first and second line of treatment in patients with NSCLC. The authors also discuss combination therapies involving immunotherapy, which allows for a better understanding of the treatment options for lung cancer. The monograph concludes with a discussion of the complications of immunotherapy and their treatment, which is extremely important for practicing physicians.

This publication is not only a source of knowledge, but also a practical guide for physicians who want to expand their knowledge on immunotherapy of lung cancer. Thanks to the detailed discussion of various aspects of treatment, readers can better understand the possibilities and limitations of this therapeutic method. This monograph is a valuable source of information for all specialists involved in the treatment of lung cancer.

The book, published by PZWL, has 162 pages, a format of 235x153 mm and a paperback cover. The year of publication is 2021.